To further explore the effect of PRL in patient cells, primary AML samples (n = 19) from each representative subgroup were treated with PRL and G129R and no significant changes were observed in terms of cell viability after a 72 h treatment (Fig. 2D). Here, PRL is linked to acute myeloid leukemia.